U.S. researchers buck embryo editing guidelines

In direct contravention of the position against germline gene editing taken by NIH, a team led by scientists from Oregon Health & Science University published a study in Nature on Wednesday detailing CRISPR-Cas9-mediated gene correction of human embryos.

The group included researchers from the Salk Institute of Biological Sciences, Korea's Institute for Basic Science, Seoul National University and BGI Group in China. Funding for the study included

Read the full 664 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers